nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—AR—scrotum—colon cancer	0.338	0.675	CbGeAlD
Oxandrolone—AR—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.0602	0.137	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDX1—colon cancer	0.0368	0.0836	CbGpPWpGaD
Oxandrolone—AR—epithelium—colon cancer	0.0268	0.0534	CbGeAlD
Oxandrolone—AR—Integrated Breast Cancer Pathway—RAD54L—colon cancer	0.026	0.0591	CbGpPWpGaD
Oxandrolone—AR—smooth muscle tissue—colon cancer	0.0258	0.0515	CbGeAlD
Oxandrolone—AR—renal system—colon cancer	0.0248	0.0495	CbGeAlD
Oxandrolone—AR—lymphoid tissue—colon cancer	0.0206	0.0411	CbGeAlD
Oxandrolone—AR—digestive system—colon cancer	0.0204	0.0406	CbGeAlD
Oxandrolone—AR—Nuclear Receptors—HNF4A—colon cancer	0.0202	0.0458	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—AXIN2—colon cancer	0.0188	0.0428	CbGpPWpGaD
Oxandrolone—AR—vagina—colon cancer	0.018	0.0359	CbGeAlD
Oxandrolone—AR—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.0159	0.0362	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ODC1—colon cancer	0.0158	0.0358	CbGpPWpGaD
Oxandrolone—AR—liver—colon cancer	0.0152	0.0303	CbGeAlD
Oxandrolone—AR—lymph node—colon cancer	0.0116	0.0232	CbGeAlD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—colon cancer	0.011	0.025	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00964	0.0219	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—PPARG—colon cancer	0.00875	0.0199	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MSH6—colon cancer	0.00859	0.0195	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MSH2—colon cancer	0.00697	0.0158	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00691	0.0157	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00658	0.0149	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—SRC—colon cancer	0.00655	0.0149	CbGpPWpGaD
Oxandrolone—Oligospermia—Methotrexate—colon cancer	0.00576	0.102	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.00554	0.0126	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—EP300—colon cancer	0.00509	0.0116	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—colon cancer	0.005	0.0113	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—PIK3CA—colon cancer	0.00498	0.0113	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—EP300—colon cancer	0.00483	0.011	CbGpPWpGaD
Oxandrolone—Bronchial hyperreactivity—Methotrexate—colon cancer	0.00463	0.0823	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—HRAS—colon cancer	0.00461	0.0105	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—colon cancer	0.0046	0.0104	CbGpPWpGaD
Oxandrolone—Azoospermia—Methotrexate—colon cancer	0.00449	0.0797	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.00443	0.0101	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—EP300—colon cancer	0.00439	0.00996	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—SRC—colon cancer	0.00427	0.00969	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CCND1—colon cancer	0.00426	0.00967	CbGpPWpGaD
Oxandrolone—Chronic obstructive pulmonary disease—Methotrexate—colon cancer	0.00423	0.0751	CcSEcCtD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CTNNB1—colon cancer	0.00422	0.00958	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—AKT1—colon cancer	0.00407	0.00924	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BAX—colon cancer	0.00395	0.00896	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.00346	0.00785	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—colon cancer	0.00343	0.00778	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—colon cancer	0.0034	0.00771	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.00339	0.00771	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.00328	0.00746	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.00327	0.00742	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—colon cancer	0.00316	0.00717	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CCND1—colon cancer	0.00315	0.00715	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.00312	0.00709	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CTNNB1—colon cancer	0.00312	0.00708	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CDKN1A—colon cancer	0.00305	0.00691	CbGpPWpGaD
Oxandrolone—Necrosis—Fluorouracil—colon cancer	0.00296	0.0526	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—EP300—colon cancer	0.0029	0.00658	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.00283	0.00642	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—SRC—colon cancer	0.00282	0.0064	CbGpPWpGaD
Oxandrolone—Hirsutism—Capecitabine—colon cancer	0.00279	0.0496	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.00277	0.00628	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—HNF4A—colon cancer	0.00275	0.00625	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—colon cancer	0.00275	0.00624	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.00272	0.00618	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.00249	0.00566	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—EGFR—colon cancer	0.00247	0.00561	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—AKT1—colon cancer	0.00237	0.00538	CbGpPWpGaD
Oxandrolone—Neoplasm—Irinotecan—colon cancer	0.00219	0.039	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.00212	0.00481	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CASP3—colon cancer	0.00206	0.00469	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.00206	0.00468	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.00204	0.00464	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.00199	0.00452	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—EP300—colon cancer	0.0019	0.00431	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.00189	0.00429	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.00189	0.00429	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—EP300—colon cancer	0.00185	0.0042	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.0018	0.00408	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.00176	0.00399	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.00175	0.00398	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—AKT1—colon cancer	0.00175	0.00398	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.00171	0.00388	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.00169	0.00384	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MYC—colon cancer	0.00165	0.00376	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.00165	0.00375	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Irinotecan—colon cancer	0.00165	0.0293	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.00162	0.00367	CbGpPWpGaD
Oxandrolone—Irritability—Fluorouracil—colon cancer	0.00161	0.0286	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.00157	0.00357	CbGpPWpGaD
Oxandrolone—Fluid retention—Capecitabine—colon cancer	0.00154	0.0274	CcSEcCtD
Oxandrolone—Necrosis—Methotrexate—colon cancer	0.00154	0.0274	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.00153	0.00347	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.00153	0.00347	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.00149	0.00338	CbGpPWpGaD
Oxandrolone—Neoplasm—Capecitabine—colon cancer	0.00147	0.0261	CcSEcCtD
Oxandrolone—Erectile dysfunction—Vincristine—colon cancer	0.00144	0.0256	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.00137	0.00311	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.00137	0.0031	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TP53—colon cancer	0.00136	0.00308	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.00134	0.00304	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—HNF4A—colon cancer	0.00132	0.00301	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.00127	0.00288	CbGpPWpGaD
Oxandrolone—Haemoglobin—Irinotecan—colon cancer	0.00122	0.0218	CcSEcCtD
Oxandrolone—Haemorrhage—Irinotecan—colon cancer	0.00122	0.0216	CcSEcCtD
Oxandrolone—AR—Generic Transcription Pathway—PPARG—colon cancer	0.00119	0.00271	CbGpPWpGaD
Oxandrolone—Haemoglobin—Fluorouracil—colon cancer	0.00117	0.0208	CcSEcCtD
Oxandrolone—Haemorrhage—Fluorouracil—colon cancer	0.00117	0.0207	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.00116	0.00264	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.00115	0.0026	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.00113	0.00256	CbGpPWpGaD
Oxandrolone—Irritability—Capecitabine—colon cancer	0.00112	0.02	CcSEcCtD
Oxandrolone—Blood creatinine increased—Capecitabine—colon cancer	0.0011	0.0196	CcSEcCtD
Oxandrolone—Neoplasm—Methotrexate—colon cancer	0.00109	0.0194	CcSEcCtD
Oxandrolone—Gynaecomastia—Methotrexate—colon cancer	0.00108	0.0192	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000951	0.00216	CbGpPWpGaD
Oxandrolone—Oedema—Vincristine—colon cancer	0.000888	0.0158	CcSEcCtD
Oxandrolone—Oedema—Irinotecan—colon cancer	0.000865	0.0154	CcSEcCtD
Oxandrolone—Irritability—Methotrexate—colon cancer	0.000837	0.0149	CcSEcCtD
Oxandrolone—Oedema—Fluorouracil—colon cancer	0.000829	0.0147	CcSEcCtD
Oxandrolone—Haemoglobin—Capecitabine—colon cancer	0.000819	0.0146	CcSEcCtD
Oxandrolone—Haemorrhage—Capecitabine—colon cancer	0.000815	0.0145	CcSEcCtD
Oxandrolone—Insomnia—Vincristine—colon cancer	0.000803	0.0143	CcSEcCtD
Oxandrolone—Insomnia—Irinotecan—colon cancer	0.000782	0.0139	CcSEcCtD
Oxandrolone—Spironolactone—ABCB1—colon cancer	0.000764	0.335	CrCbGaD
Oxandrolone—Insomnia—Fluorouracil—colon cancer	0.000749	0.0133	CcSEcCtD
Oxandrolone—Norethindrone—ABCB1—colon cancer	0.000709	0.311	CrCbGaD
Oxandrolone—Erectile dysfunction—Methotrexate—colon cancer	0.000698	0.0124	CcSEcCtD
Oxandrolone—AR—Generic Transcription Pathway—MYC—colon cancer	0.000681	0.00155	CbGpPWpGaD
Oxandrolone—Haemoglobin—Methotrexate—colon cancer	0.00061	0.0108	CcSEcCtD
Oxandrolone—Haemorrhage—Methotrexate—colon cancer	0.000607	0.0108	CcSEcCtD
Oxandrolone—Oedema—Capecitabine—colon cancer	0.000579	0.0103	CcSEcCtD
Oxandrolone—AR—Gene Expression—PPARG—colon cancer	0.000575	0.00131	CbGpPWpGaD
Oxandrolone—Insomnia—Capecitabine—colon cancer	0.000524	0.00931	CcSEcCtD
Oxandrolone—Progesterone—ABCB1—colon cancer	0.000413	0.182	CrCbGaD
Oxandrolone—Testosterone—ABCB1—colon cancer	0.000391	0.172	CrCbGaD
Oxandrolone—Insomnia—Methotrexate—colon cancer	0.00039	0.00693	CcSEcCtD
Oxandrolone—AR—Gene Expression—MYC—colon cancer	0.000328	0.000744	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—AKT1—colon cancer	0.000227	0.000516	CbGpPWpGaD
